Miniature model of the human nose reveals early events of SARS-CoV-2 and RSV infection
Researchers anticipate that the human nose organoid system would help accelerate the transfer of lab-developed therapeutics to the bedside.
Read moreResearchers anticipate that the human nose organoid system would help accelerate the transfer of lab-developed therapeutics to the bedside.
Read moreVariation of human immune response to RSV reinfection suggests it is important to consider this variation in vaccine design.
Read more